Transplant stories

Real Treatments. Real Families. Real Hope.

Smart Cells was the first private UK stem cell bank to release samples for transplant — proving that family cord blood banking is not just about storage, but about delivering real therapies when they are needed most.

Why Stem Cell Transplants Matter

At some point in life, your child or family member may need access to stem cell therapy. Today, these treatments are being used for:

Blood cancers such as leukaemia and lymphoma
Inherited genetic disorders including thalassemia and sickle cell disease
Neurological conditions such as cerebral palsy and brain injury
Immune deficiencies and metabolic disorders
Emerging therapies for sports injuries, inflammatory conditions, and skin repair

By preserving your baby’s umbilical cord blood and tissue, you safeguard access to these life-saving and life-enhancing possibilities.

Proven Track Record

Smart Cells has released more stem cell samples for treatment than any other private UK bank, with a 100% success rate for every sample delivered to clinicians worldwide.

These samples have helped children and families across the globe face illnesses such as:

Cerebral Palsy
Thalassemia
Leukaemia
HSV Encephalitis
Immune system disorders

Each transplant is more than a statistic — it represents a child given new options, and a family given hope.

A Milestone for Families and for Science

Every successful release shows how far the field of stem cell research has advanced. What was once only a possibility is now a proven therapy.

Yet many parents are still unaware of the benefits of storing their baby’s cord blood and tissue. Smart Cells is working to change that — by raising awareness, sharing real transplant stories, and supporting research into the next generation of regenerative treatments.

Powered by FamiCord: Europe’s Stem Cell Leader in banking and use of cells

As part of the FamiCord Group, Europe’s largest family stem cell bank and one of the world’s top three:

Families gain access to 1,000,000+ stored cord blood units across the network
Therapies are supported by specialist research centres and clinical teams in 35+ countries including FamiCord Programme for brain disorders
FamiCordTx, the group’s advanced therapies division, is actively developing new cell-based treatments to extend the possibilities for families everywhere

Together, Smart Cells and FamiCord stand at the forefront of innovation, offering parents confidence today — and hope for tomorrow.

Order now Find out more

FamiCord Group releases

Patients

7800+

Expand table
No.	Source	Source type	Diagnosis	Medical sector	Year of application	Therapy	Country	Age of the recipient
7701	Bone Marrow	Allogeneic	Digeorge Syndrome	Hematology	2016	Standard Therapy	Poland	24
7702	Bone Marrow	Allogeneic	Fanconi Anemia	Hematology	2016	Standard Therapy	Poland	7
7703	Bone Marrow	Allogeneic	Fanconi Anemia	Hematology	2016	Standard Therapy	Poland	41
7704	Bone Marrow	Allogeneic	High-Risk Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	18
7705	Bone Marrow	Allogeneic	Hodgkin Lymphoma	Hematology	2016	Standard Therapy	Poland	17
7706	Bone Marrow	Allogeneic	Hurler Syndrome	Metabolic	2016	Standard Therapy	Poland	2
7707	Bone Marrow	Allogeneic	Juvenile Myelomonocytic Leukemia	Hematology	2016	Standard Therapy	Poland	3
7708	Bone Marrow	Allogeneic	Myelodysplastic Syndrome	Hematology	2016	Standard Therapy	Poland	1
7709	Bone Marrow	Allogeneic	Myelodysplastic Syndrome	Hematology	2016	Standard Therapy	Poland	56
7710	Bone Marrow	Allogeneic	Myelofibrosis	Hematology	2016	Standard Therapy	Poland	31
7711	Bone Marrow	Allogeneic	Myeloproliferative Syndrome	Hematology	2016	Standard Therapy	Poland	22
7712	Bone Marrow	Allogeneic	No Data	no data	2016	Standard Therapy	Poland	3
7713	Bone Marrow	Allogeneic	No Data	no data	2016	Standard Therapy	Poland	7
7714	Bone Marrow	Allogeneic	No Data	Hematology	2016	Standard Therapy	Poland	33
7715	Bone Marrow	Allogeneic	Non-Hodgkin Lymphoma	Hematology	2016	Standard Therapy	Poland	46
7716	Bone Marrow	Allogeneic	Osteopetrosis	Metabolic	2016	Standard Therapy	Poland	6
7717	Bone Marrow	Allogeneic	Osteopetrosis	Metabolic	2016	Standard Therapy	Poland	1
7718	Bone Marrow	Allogeneic	Severe Aplastic Anemia	Hematology	2016	Standard Therapy	Poland	9
7719	Bone Marrow	Allogeneic	Severe Aplastic Anemia	Hematology	2016	Standard Therapy	Poland	9
7720	Bone Marrow	Allogeneic	Severe Aplastic Anemia; Paroxysmal Nocturnal Hemoglobinuria	Hematology	2016	Standard Therapy	Poland	17
7721	Bone Marrow	Allogeneic	Severe Combined Immunodeficiency	Hematology	2016	Standard Therapy	Poland	2
7722	Bone Marrow	Allogeneic	Severe Combined Immunodeficiency	Hematology	2016	Standard Therapy	Poland	4
7723	Bone Marrow	Allogeneic	Severe Combined Immunodeficiency	Hematology	2016	Standard Therapy	Poland	7 months
7724	Bone Marrow	Allogeneic	Severe Combined Immunodeficiency	Hematology	2016	Standard Therapy	Poland	12
7725	Bone Marrow	Allogeneic	T-Cell Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	4
7726	Bone Marrow	Allogeneic	Thalassemia Major	Hematology	2016	Standard Therapy	Germany	18
7727	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	56
7728	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	43
7729	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	61
7730	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	24
7731	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	13
7732	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	58
7733	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	20
7734	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	23
7735	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	27
7736	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	30
7737	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	37
7738	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	38
7739	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	28
7740	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	30
7741	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	39
7742	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	66
7743	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	20
7744	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	56
7745	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	9
7746	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	33
7747	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	21
7748	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Poland	35
7749	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Germany	57
7750	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Germany	29
7751	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Germany	1
7752	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2016	Standard Therapy	Germany	42
7753	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia – Relapse	Hematology	2016	Standard Therapy	Germany	27
7754	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	58
7755	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	62
7756	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	40
7757	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	18
7758	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	66
7759	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	64
7760	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	54
7761	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	54
7762	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	18
7763	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	31
7764	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	35
7765	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	46
7766	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	29
7767	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	32
7768	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	49
7769	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	64
7770	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	42
7771	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	13
7772	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	8
7773	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	46
7774	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	40
7775	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	32
7776	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	66
7777	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	43
7778	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	66
7779	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	47
7780	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	15
7781	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	37
7782	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	57
7783	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	56
7784	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	52
7785	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	35
7786	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	72
7787	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	46
7788	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	51
7789	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	62
7790	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	69
7791	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	51
7792	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	55
7793	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	63
7794	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	65
7795	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	46
7796	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	18
7797	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	48
7798	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	67
7799	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	59
7800	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2016	Standard Therapy	Poland	9 months

Page 78 of 89 1 76 77 78 79 80 89

Expand table

Stem cell transplantation has become an established procedure

700,000

cord blood collections have been undertaken globally

50,000

hematopoietic stem cell transplants take place every year

400/500

of these transplants are in Europe

Our transplant stories

Smart Cells have released 24 UK
samples to six countries.

Stem cells hold the key to more than 80 life-changing treatments, with clinical trials underway on many more. Replacing damaged cells and tissue, they can even save a child’s life.

100% infusion success rate

For samples released for transplant.

3 months – 12 yrs old

Stored cord blood samples have been successfully released for use in transplant for children aged as little as 3 months to 12 years old.

46% self | 54% siblings

Smart Cells have successfully released stored cord blood samples that have been used for treatment with the child it was collected from and also siblings.

Smart Cells releases

UK samples released

Expand table
Sample release date	Medical condition	Recipient relationship	Age of the recipient	Unit volume	Medical center	Country
2005.11	Thalassemia	Allogeneic (Sibling)	4 Years	144ml	Mount Vernon Hospital	Singapore
2005.11	Leukaemia	Allogeneic (Sibling)	Restricted	Restricted	Stem Cells and Immunology Department, Birmingham	UK
2007.02	Thalassemia	Allogeneic (Sibling)	7 Years	76ml	Kinderlink der Tu Munchen	Germany
2009.08	Cerebral Palsy	Autologous (Self)	3 Years	51ml	Duke University, North Carolina	USA
2010.01	Cerebral Palsy	Autologous (Self)	3 Years	81ml	Duke University, North Carolina	USA
2013.10	Thalassemia	Allogeneic (Sibling)	5 Years	58ml	Catherine Lewis Centre, Hammersmith	UK
2014.01	Leukaemia	Allogeneic (Sibling)	4 Years	71ml	Medizinische Hochschule, Hanover	Germany
2014.05	Cerebral Palsy	Autologous (Self)	1 year	68ml	Duke University, North Carolina	USA
2014.06	HSV Encephalitis & NMDA Receptor Antibody Virus	Autologous (Self)	2 Years	57ml	Duke University, North Carolina	USA
2014.08	Hypoxic Ischemic Encephalopathy (HIE)	Autologous (Self)	3 Months	39ml	Duke University, North Carolina	USA
2015.02	Hypoxic Ischemic Encephalopathy (HIE)	Autologous (Self)	6 Months	53ml	Duke University, North Carolina	USA
2015.03	Severe Combined Immune Deficiency	Autologous (Self)	3 Months	74ml	Duke University, North Carolina	USA
2015.03	Sickle Cell Disease	Allogeneic (Sibling)	2 .5 Years	57ml	BLK Hospital, New Delhi	India
2015.11	Thalassemia	Allogeneic (Sibling)	12 Years	87ml	Children’s Hospital of Pittsburgh of UPMC	USA
2016.03	Cerebral Palsy	Allogeneic (Sibling)	6 Years	101ml	Duke University, North Carolina	USA
2017.04	Lymphoblastic Leukaemia (^1)	N/A (Identical twin girls)	Restricted	125ml	Bambin Gesu Childrens’ Hospital, Rome	Italy
2017.06	Cerebral Palsy	Autologous (Self)	7 Years	82ml	Duke University, North Carolina	USA
2017.06	Cerebral Palsy	Autologous (Self)	3.4 Years	132ml	Duke University, North Carolina	USA
2018.03	Autism	Autologous (Self)	5.4 Years	73ml	Duke University, North Carolina	USA
2018.03	Cerebral Palsy	Autologous (Self)	3.4 years	132ml	Duke University, North Carolina	USA
2019.06	Cerebral Palsy	Allogeneic (Sibling)	3 Years	104ml	Duke University, North Carolina	USA
2022.02	Cerebral Palsy	Allogeneic (Sibling)	11 Years	185ml	Duke University, North Carolina	USA
2023.08	Cerebral Palsy	Allogeneic (Sibling)	3 Years	46ml	Duke University, North Carolina	USA
2024.01	Thalassaemia	Allogeneic (Sibling)	8 Years	45ml	Cincinnati Children’s Hospital Medical Center	USA